Concepedia

Inhibition of JAK1/2 can overcome EGFR-TKI resistance in human NSCLC

Dong Min Kim, Mi Jin Kim, Jai-Hee Moon, Eun Young Lee, Jun Ki Hong, Seul Lee, Dong‐In Koh, Seung Mi Kim, Soo-A Jung, Jae-Sik Shin,

Biochemical and Biophysical Research Communications · 2020 · 14 citations · 12 references

DOI

Concepts

References

12

The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours

Sally Thomas, John A. Snowden, Martin P. Zeidler et al. · British Journal of Cancer · 2015 · 642 citations · Full text

, , +14

Epidermal Growth Factor Receptor Mediates Increased Cell Proliferation, Migration, and Aggregation in Esophageal Keratinocytes in Vitro and in Vivo

Claudia D. Andl, Takaaki Mizushima, Hiroshi Nakagawa et al. · Journal of Biological Chemistry · 2003 · 250 citations · Full text

, , +15

EGFR-TKI resistance in NSCLC patients: mechanisms and strategies.

Yuxin Lin, Xian Wang, Hongchuan Jin · PubMed · 2014 · 183 citations

, , +17

The <i>EGFR</i> T790M Mutation in Acquired Resistance to an Irreversible Second-Generation EGFR Inhibitor

Young-Wook Kim, Jeong‐Hun Ko, Zheng-Yun Cui et al. · Molecular Cancer Therapeutics · 2012 · 175 citations · Full text

, , +15

JAK inhibitors for the treatment of myeloproliferative neoplasms and other disorders

William Vainchenker, Emilie Leroy, Laure Gilles et al. · F1000Research · 2018 · 157 citations · Full text

, , +13